What infections can cause pancytopenia?

Infections That Cause Pancytopenia

Multiple infections can cause pancytopenia, with the most clinically significant being HIV (particularly advanced disease), visceral leishmaniasis (kala-azar), brucellosis, miliary tuberculosis, parvovirus B19, and severe viral infections including COVID-19, CMV, and HSV in immunocompromised hosts.

Primary Infectious Causes by Clinical Priority

HIV/AIDS - Most Common Globally

• Advanced HIV infection (WHO Stage 3-4) is an independent risk factor for pancytopenia (aOR 2.88) and represents the leading infectious cause in endemic areas 1
• Pancytopenia occurs in approximately 5% of people living with HIV, with annual incidence of 2.82% 1
• Mechanism: Direct bone marrow suppression, opportunistic infections, and medication toxicity
• Critical point: Life-threatening anemia (Hgb <65 g/L) predicts irreversibility and significantly impairs survival 1

Visceral Leishmaniasis (Kala-azar)

• Classic triad: chronic fever, splenomegaly, and pancytopenia 2
• Associated findings: weight loss, hypoalbuminemia, elevated inflammatory markers, hyperpigmentation (in India/Bangladesh) 2
• Accounts for 9% of pancytopenia cases in endemic regions 3
• Reactivation risk: Can occur years to decades after exposure, especially in immunocompromised patients (AIDS, transplant recipients, TNF-α antagonist users) 2

Brucellosis

• Presents with fever (often relapsing), lymphadenopathy, hepatosplenomegaly 4
• Initial labs show mild transaminitis and pancytopenia 4
• Rare but serious complication: Hemophagocytic syndrome causing severe pancytopenia 5
• Diagnosis: Bone marrow culture has highest sensitivity; blood cultures 15-70% sensitive (requires prolonged culture up to 4 weeks) 4

Miliary Tuberculosis

• Part of differential for subacute/chronic pancytopenia with fever 2
• Identified as a cause in pediatric pancytopenia studies 6
• Consider in patients with prolonged fever, weight loss, and systemic symptoms

Viral Infections

Parvovirus B19

• Documented cause of pancytopenia, particularly in immunocompromised hosts 6
• Direct bone marrow suppression

COVID-19

• Can cause pancytopenia presenting months after initial infection 7
• May develop persistent neutropenia despite initial response to IVIG and steroids 7

CMV and HSV

• Frequently encountered in neutropenic patients, especially post-bone marrow transplant 8
• Empiric acyclovir in seropositive allogeneic BMT patients significantly reduces morbidity 8

Other Infectious Causes

• Enteric fever (typhoid): Acute presentation with pancytopenia 3
• Falciparum malaria: Reversible cause, particularly in endemic areas 3
• Fungal infections (Candida, Aspergillus): Typically after prolonged neutropenia (>7-10 days), not initial presentation 9

Clinical Approach Algorithm

Step 1: Risk Stratification

Identify high-risk populations:

• Advanced HIV (WHO Stage 3-4)
• Travel/residence in endemic areas (leishmaniasis, brucellosis, malaria)
• Immunocompromised states (transplant, biologics, chemotherapy)
• Occupational exposure (farmers, veterinarians for brucellosis)

Step 2: Targeted Diagnostic Workup

Essential initial tests:

• HIV testing (should be routine in pancytopenia workup) 4
• Bone marrow examination with culture (highest yield for brucellosis, leishmaniasis) 4, 2
• Blood cultures (prolonged incubation for brucellosis)
• Serology: Brucella, Leishmania, parvovirus B19, CMV, HSV
• Chest imaging for miliary TB

Geographic/exposure-based:

• Leishmania serology/PCR if endemic area exposure 2
• Malaria smears in appropriate context 3

Step 3: Management Priorities

For active infection with pancytopenia:

• Do NOT delay treatment of life-threatening infection 10
• Initiate appropriate antimicrobials immediately (within 2 hours for neutropenic fever) 9
• Consider less myelosuppressive regimens when treating concurrent malignancy 10

Specific treatments:

• HIV: Effective antiretroviral therapy is priority; most pancytopenia resolves with viral control and immune recovery 1
• Brucellosis: Responds favorably to appropriate antibiotics 5
• Leishmaniasis, malaria, enteric fever: Treatable and reversible causes 3

Critical Pitfalls to Avoid

1. Delaying infection workup: Pancytopenia with fever requires urgent evaluation; 50-60% of febrile neutropenic patients have established or occult infection 11

2. Missing reversible causes: Infections (kala-azar, malaria, enteric fever, brucellosis) are treatable; early diagnosis is life-saving 3

3. Overlooking HIV: Should be routinely tested in pancytopenia, especially with fever, unexplained lymphadenopathy, or prolonged symptoms 4

4. Inadequate culture techniques: Brucellosis requires special laboratory precautions and prolonged culture 4

5. Ignoring reactivation risk: Leishmaniasis can reactivate decades after exposure in immunocompromised patients 2

6. Underestimating severity markers: Life-threatening anemia (Hgb <65 g/L) predicts poor outcomes 1; history of pancytopenia significantly impairs survival 1

The key principle: Pancytopenia from infection is often reversible with appropriate treatment, but requires prompt recognition and aggressive management to prevent mortality 3, 1.